U.S. military spending on the war in Iraq has nearly matched the cost of the war in Vietnam, according to a new Congressional Research Service analysis (pdf) of the financial costs of wars throughout U.S. history. And total post-9/11 U.S. military spending has exceeded the cost of Vietnam by a considerable margin.
The ongoing war in Iraq has incurred an estimated $648 billion to date, and total post-9/11 military spending including the Iraq War, Afghanistan and other terrorism-related military expenditures has reached $859 billion, the CRS reported.
The Vietnam War (1965-1975) cost an estimated $686 billion in 2008 dollars, the CRS said.
The total cost of the American Revolution (1775-1783) was $101 million, or about $1.8 billion in 2008 dollars.
The cost of World War II (1941-1945) was about $4.1 trillion in 2008 dollars, and consumed a massive 35.8% of gross domestic product. The Iraq war represents 1% of GDP today.
These estimates include various caveats and limitations spelled out by CRS.
“All estimates are of the costs of military operations only and do not include costs of veterans benefits, interest paid for borrowing money to finance wars, or assistance to allies,” the CRS report indicated.
“Comparisons of costs of wars over a 230 year period… are inherently problematic,” the new report cautioned. See “Costs of Major U.S. Wars,” Congressional Research Service, July 24, 2008.
Nearly 150 organizations and government officials have endorsed the call to action and solutions for extreme heat, now public at HeatAgenda.US Washington, D.C. – July 7, 2026 – As millions of Americans continue to struggle to stay cool following one of the hottest Independence Day holidays on record, the Federation of American Scientists (FAS), one […]
Addressing rising heat will take all of us. Together, we can create heat-safe homes, workplaces, schools, childcare facilities, and communities – the backbone of a heat-ready nation.
We sat down with biomedical research pioneer Lee Hood to talk moonshots, metascience in medicine, and the Human Phenome Initiative.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.